Pediatric cancer recurrence prediction is at the forefront of a groundbreaking new study that leverages AI technology to enhance outcomes for children facing gliomas and other brain tumors.Traditional methods of assessing relapse risk have proven inadequate, demanding frequent and sometimes anxiety-inducing imaging procedures for young patients and their families.